Bryan Johnson, a 48-year-old tech CEO, has dedicated a significant portion of his wealth to the pursuit of anti-aging solutions. His annual expenditure on these treatments reaches an astonishing $2 million.
Among the various procedures he has undergone, Johnson has even resorted to blood transfusions from his teenage son, Talmage, in hopes of reversing the aging process.
However, despite his extensive efforts and financial commitment, Johnson has recently disclosed that he is facing an incurable disease, highlighting the limitations of current medical advancements in the realm of anti-aging.